KRAS and hepatocellular carcinoma: In summary, miR-622 exhibits potent tumor-suppressive functions in HCC and in melanoma via affection of several relevant target genes and mechanisms, respectively, with KRAS being the major target responsible for miR-622’s inhibitory effect on HCC proliferation and clonogenicity [5,109,118].